Related Experiment Video
Updated: Oct 21, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
PLGA-Encapsulated Cross-Linked GALC Aggregates as a Hierarchical Nanostructured Platform for Enzyme Stabilization and
Laura Colagiorgio1,2, Mariacristina Gagliardi1, Ambra Del Grosso1
1Istituto Nanoscienze - CNR, NEST-SNS Piazza San Silvestro 12 56126 Pisa Italy.
Abstract:
Enzyme aggregation and polymer encapsulation are complementary strategies used to overcome the intrinsic instability and limited bioavailability of hydrophilic enzymes in medical uses. In this work, we report a systematic study of polymer-encapsulated cross-linked enzyme aggregates (pe-CLEAs) as a hierarchical nanostructured platform for the stabilization and delivery of galactosylceramidase (GALC), a lysosomal enzyme used in the enzyme replacement therapy for Krabbe disease. GALC-CLEAs were produced via cross-linking and controlled precipitation, yielding stable aggregates with small hydrodynamic diameters (40-66 nm) and narrow polydispersity index (PDI < 0.1). Scaling up the synthesis by 50-fold markedly enhanced total enzymatic output, reaching 1225.4 ± 213.2 U·mL-1. GALC-CLEAs were subsequently encapsulated within PLGA nanoparticles. Systematic screening of enzyme-to-polymer ratios revealed an optimal formulation at 75 μg GALC per mg PLGA, displaying a maximum specific activity of 6.0 ± 1.3 U·mg-1. Colloidal stability and retention assays showed that pe-CLEAs preserved full catalytic activity and retained enzyme confinement over 30 days at 4°C. At 37°C, pe-CLEAs exhibited time-dependent size dynamics while retaining substantial activity. In vitro evaluations in primary fibroblasts derived from Twitcher mice (a Krabbe disease model) demonstrated complete cytocompatibility up to 5.0 mg·mL-1 and robust intracellular recovery of GALC activity across tested doses (0.5-5.0 mg·mL-1), outperforming equivalent doses of native enzyme. This work provides a comprehensive physicochemical and functional characterization of pe-CLEAs, elucidating how hierarchical aggregation and polymer encapsulation can synergistically preserve stability and bioactivity. The design principles outlined here support the rational development of polymer-enzyme nanocarriers for enzyme replacement therapy and related biomedical applications.

